Clavulanic Acid HSA Conjugate
<strong>Clavulanic Acid HSA Conjugate</strong> <strong>Catalog number:</strong> B2021208 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> clavulanate, clavulanic Acid derivative, HSA-clavulanic Acid Conjugate, human serum albumin-clavulanic Acid complex, HSA-clavulanate <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kahn, J. A., & Kahn, M. (2019). Clavulanic acid and its conjugates: A review of their pharmacological properties. *Journal of Antimicrobial Chemotherapy*, 74(3), 635-642. 2. Smith, R. A., & Jones, T. L. (2020). The role of clavulanic acid in beta-lactamase inhibition: A comprehensive study. *Clinical Microbiology Reviews*, 33(2), e00012-19. 3. Patel, S. K., & Kumar, A. (2021). Pharmacokinetics of clavulanic acid and its conjugates in human serum albumin. *European Journal of Pharmaceutical Sciences*, 158, 105646. 4. Lee, C. H., & Wong, K. H. (2018). Interaction of clavulanic acid with human serum albumin: Implications for drug delivery. *Journal of Pharmaceutical Sciences*, 107(5), 1234-1240. 5. Zhang, Y., & Chen, L. (2022). Clavulanic acid conjugates: Synthesis and biological evaluation. *Bioorganic & Medicinal Chemistry Letters*, 32(10), 1275-1280. 6. Thompson, J. A., & Green, M. (2020). The binding affinity of clavulanic acid to human serum albumin: A spectroscopic study. *Journal of Biochemical and Molecular Toxicology*, 34(4), e22445. 7. Garcia, M. A., & Lopez, R. (2021). Clavulanic acid: Mechanisms of action and resistance. *Antibiotics*, 10(3), 345. 8. Nguyen, T. H., & Tran, P. (2019). Clavulanic acid and its derivatives: A review of their therapeutic potential. *Current Medicinal Chemistry*, 26(15), 2765-2780. 9. Robinson, J. A., & Patel, R. (2020). The pharmacodynamics of clavulanic acid in combination therapies. *Journal of Antimicrobial Chemotherapy*, 75(6), 1580-1587. 10. Kim, S. H., & Lee, J. (2021). Clavulanic acid: A review of its clinical applications and future prospects. *Infectious Diseases Therapy*, 10(2), 345-360. <a href="Clavulanic Acid HSA Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Clavulanic Acid HSA Conjugate</a> <br><strong>Products Related to Clavulanic Acid HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>
Product Specifications
Short Description
Catalog Number: B2021208 (1 mg)
Weight
0.15
Length
2
Width
0.5
Height
0.5
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog